These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22457621)
1. A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. Barrett BS; Smith DS; Li SX; Guo K; Hasenkrug KJ; Santiago ML PLoS Pathog; 2012; 8(3):e1002596. PubMed ID: 22457621 [TBL] [Abstract][Full Text] [Related]
2. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717 [TBL] [Abstract][Full Text] [Related]
3. Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. Li SX; Barrett BS; Heilman KJ; Messer RJ; Liberatore RA; Bieniasz PD; Kassiotis G; Hasenkrug KJ; Santiago ML J Immunol; 2014 Jul; 193(1):306-16. PubMed ID: 24872193 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral restriction factors in mice. Nair S; Rein A Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of retroviral restriction factors involved in resistance to porcine endogenous retrovirus. Bae EH; Jung YT J Microbiol Biotechnol; 2014 Apr; 24(4):577-83. PubMed ID: 24448163 [TBL] [Abstract][Full Text] [Related]
10. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Liberatore RA; Bieniasz PD Proc Natl Acad Sci U S A; 2011 Nov; 108(44):18097-101. PubMed ID: 22025715 [TBL] [Abstract][Full Text] [Related]
11. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895 [TBL] [Abstract][Full Text] [Related]
12. Early Vertebrate Evolution of the Host Restriction Factor Tetherin. Heusinger E; Kluge SF; Kirchhoff F; Sauter D J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043 [TBL] [Abstract][Full Text] [Related]
13. CAML does not modulate tetherin-mediated restriction of HIV-1 particle release. Ali MS; Hammonds J; Ding L; Spearman P PLoS One; 2010 Feb; 5(2):e9005. PubMed ID: 20126395 [TBL] [Abstract][Full Text] [Related]
14. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169 [TBL] [Abstract][Full Text] [Related]
15. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. Janvier K; Pelchen-Matthews A; Renaud JB; Caillet M; Marsh M; Berlioz-Torrent C PLoS Pathog; 2011 Feb; 7(2):e1001265. PubMed ID: 21304933 [TBL] [Abstract][Full Text] [Related]
16. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436 [TBL] [Abstract][Full Text] [Related]
17. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700 [TBL] [Abstract][Full Text] [Related]
18. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289 [TBL] [Abstract][Full Text] [Related]